Prognostic role of soluble ST2 in acute coronary syndrome with diabetes.

Durga JhaLuxitaa GoenkaThilagavathi RamamoorthyMasum SharmaVellala E DhandapaniMelvin George

Published in: European journal of clinical investigation (2018)

The current study indicates that elevated levels of sST2 might be a suitable biomarker to evaluate the risk of future adverse cardiovascular events in ACS patients with diabetes.

Keyphrases

cardiovascular events
acute coronary syndrome
cardiovascular disease
coronary artery disease
percutaneous coronary intervention
antiplatelet therapy
type diabetes
current status
emergency department
glycemic control
atrial fibrillation
metabolic syndrome
weight loss
adverse drug